This multisession course considers the clinical potential of molecular imaging in management of cardiovascular diseases. Experts review molecular methods for imaging plaque, stem cell labeling for noninvasive imaging, the future of cardiovascular molecular imaging and more.
When: Tuesday, Nov. 29, 8:30-12:00
King C. Li, MD, director, department of translational imaging, Methodist Hospital Research Institute, Houston
Zahi Fayad, PhD, director, Translational and Molecular Imaging Institute, Mount Sinai Medical Center, New York City
Farouc Jaffer, MD, PhD, director, cardiovascular molecular imaging program, Massachusetts General Hospital, Boston